VTVT stock forecast
Our latest prediction for vTv Therapeutics Inc's stock price was made on the Dec. 17, 2020 when the stock price was at 2.12$.
In the short term (2weeks), VTVT's stock price should outperform the market by 5.59%. During that period the price should oscillate between -11.60% and +21.45%.
In the medium term (3months), VTVT's stock price should underperform the market by -4.20%. During that period the price should oscillate between -47.12% and +46.05%.
Get email alertsCreate a solid portfolio with VTVT
About vTv Therapeutics Inc
vtv therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of human therapeutics to fill unmet medical needs. our mission is to utilize our innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines. we have a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, diabetes and metabolic disorders, inflammation and cancer.
At the moment the company generates 10M USD in revenues.
On its last earning announcement, the company reported a loss of -0.07$ per share.
The book value per share is -0.75$
Three months stock forecastDec. 17, 2020
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
10M | - | -9M | -83.90% | -5M | -0.07 | - | - | 57M | -0.75 | -15M | - | -15M |